|
GENUV to participate in the 2021 J.P. Morgan Healthcare Conference
GENUV announced its participation in the upcoming J.P. Morgan Healthcare Conference, which takes place virtually on January 11-14, 2021.
The J.P. Morgan Healthcare Conference, in its 39th year, is an invitation-only annual event held in January that invites global biopharma companies to share new technologies and discuss business development strategies.
According to GENUV, the company is developing therapeutics to treat neurodegenerative diseases such as ALS(Lou Gehrig’s disease) and Alzheimer’s disease through new approaches based on the novel mode of action of neural regeneration and neural homeostasis in addition to “ATRIVIEW”, an in-house developed screening platform for the discovery of new drugs.
With these solid developments in progress, GENUV has raised an additional 12.5 billion won between Nov-Dec 2020 via Pre-Series C funding.
....
(Translated by GENUV)
To view original article, please click here.
|
